SCHOTT Pharma has inaugurated a new manufacturing facility in central Serbia.

The company’s investment has been realized with the start of glass ampoule production, which will create around 180 jobs by the end of 2025. With this step, SCHOTT Pharma is increasing its competitiveness in the field of drug containment solutions and is building the largest ampoule manufacturing facility in Europe.

“At a time when global tariffs and duties are rising and other European-based glass ampoule manufacturers are closing their doors, we can offer our regional customers a clear long-term perspective on how to secure their local supply chain,” said Andreas Reisse, CEO of SCHOTT Pharma.

The new site in Jagodina will manufacture glass ampoules for the storage of injectable medications such as analgesics, anti-inflammatories and anesthetics.

SCHOTT Pharma’s new ampoule production in Serbia will continue to help the pharmaceutical industry deliver medicines to patients safely. The facility is equipped with modern manufacturing technology and inspection systems to produce products to the highest quality standards.

SCHOTT Pharma’s Type I borosilicate glass ampoule portfolio ranges from clear or amber glass types to different shapes (B, C, D) and breakage systems (one point cut, scoring, color break) and is available with or without printing. It includes more than a thousand different articles, all manufactured in accordance with current Good Manufacturing Practices (cGMP). To meet the demanding requirements of modern drug manufacturing, SCHOTT Pharma ampoules emphasize uniform dimensions and exceptional cosmetic quality to ensure seamless compatibility with automated filling lines, minimize downtime and reduce waste. As a result, they meet evolving industry standards and requirements and help pharmaceutical companies optimize efficiency and achieve product integrity, contributing to long-term cost savings.

With the new site in Serbia, SCHOTT Pharma adds another location to its global manufacturing network, which now includes 15 countries.